tm logo
E&S HEALTHCARE
Live/Pending
PUBLISHED FOR OPPOSITION

on 10 Sep 2024

Last Applicant/ Owned by

#N313, 11-3, Techno 1-ro, Yuseong-gu

Daejeon

KR

34015

Serial Number

90031610 filed on 01st Jul 2020

Registration Number

N/A

Correspondent Address

Max Vern

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP

NEW YORK, NY 10016

UNITED STATES

Filing Basis

1. intent to use

Disclaimer

NO DATA

E&S HEALTHCARE

Medical device for detecting cancer; medical device, namely, in vitro diagnostic medical device for detecting breast cancer by Thioredoxin 1(Trx1) expression level; medical device for breast cancer detection for medical use, namely breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes,, anti-Thioredoxin 1(Trx 1) antibo Read More

Classification Information


Class [010]
Medical Instrument Products


Medical device for detecting cancer; medical device, namely, in vitro diagnostic medical device for detecting breast cancer by Thioredoxin 1(Trx1) expression level; medical device for breast cancer detection for medical use, namely breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes,, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus for detecting cancer and testing for viruses; apparatus for blood testing for medical use; medical device and apparatus in the field of clinical diagnosis, namely, a breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes, antiThioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; testing instruments for medical diagnostic purposes, namely, a breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; tools for medical diagnostics, namely, a breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposes, anti-Thioredoxin 1(Trx 1) antibody coated 96-well plate, Trx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; blood analysis apparatus for diagnosis.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Diagnostic reagents for medical use for immune disease; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; immunoassay diagnostic reagents for medical purposes; biological reagents for medical purposes, biological reagents for medical diagnostic purposes; reagents for medical diagnostic purposes for the analysis of body fluids; reagent paper for medical purposes; medicated lozenges; chemical reagents for medical purposes; diagnostic reagents for medicinal use; clinical medical reagents; clinical diagnostic reagents in the nature of clinical medical reagents


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 90031610

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 28193/49

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Sep 2024PUBLISHED FOR OPPOSITION
21st Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
08th Aug 2024EXAMINERS AMENDMENT E-MAILED
08th Aug 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08th Aug 2024EXAMINERS AMENDMENT -WRITTEN
08th Aug 2024EXAMINER'S AMENDMENT ENTERED
08th May 2024NOTIFICATION OF FINAL REFUSAL EMAILED
08th May 2024FINAL REFUSAL E-MAILED